Teva Pharmaceutical Industries Ltd. (TEVA)
30.03
-0.06
(-0.20%)
USD |
NYSE |
Mar 18, 13:51
Teva Pharmaceutical Industries EPS Diluted (Quarterly) : 0.4118 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanofi | -- |
| Johnson & Johnson | 2.098 |
| Compugen Ltd. | 0.6002 |
| Royalty Pharma Plc | 0.4992 |
| Pluri, Inc. | -0.7066 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 483.00M |
| Revenue (Quarterly) | 4.755B |
| Total Expenses (Quarterly) | 4.272B |
| Enterprise Value | 48.68B |
| Gross Profit Margin (Quarterly) | 56.49% |
| Profit Margin (Quarterly) | 10.16% |
| Earnings Yield | 4.06% |
| Operating Earnings Yield | 11.43% |
| Normalized Earnings Yield | 7.476 |